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Hair follicle stem cells (bulge cells) are essential for
hair regeneration and early epidermal repair after
wounding. Here we show that Brg1, a key enzyme
in the chromatin-remodeling machinery, is dynami-
cally expressed in bulge cells to control tissue re-
generation and repair. In mice, sonic hedgehog
(Shh) signals Gli to activate Brg1 in bulge cells to
begin hair regeneration, whereas Brg1 recruits
NF-kB to activate Shh in matrix cells to sustain hair
growth. Such reciprocal Brg1-Shh interaction is
essential for hair regeneration. Moreover, Brg1 is
indispensable for maintaining the bulge cell reser-
voir. Without Brg1, bulge cells are depleted over
time, partly through the ectopic expression of the
cell-cycle inhibitor p27Kip1. Also, bulge Brg1 is acti-
vated by skin injury to facilitate early epidermal
repair. Our studies demonstrate a molecular circuit
that integrates chromatin remodeling (Brg1), tran-
scriptional regulation (NF-kB, Gli), and intercellular
signaling (Shh) to control bulge stem cells during
tissue regeneration.
INTRODUCTION
Each hair follicle goes through cycles of anagen (growth), cata-
gen (regression), and telogen (quiescence) phases for repeated
bouts of hair regeneration (Alonso and Fuchs, 2006). Hair follicles
also contribute to early epidermal repair after skin injury (Ito and
Cotsarelis, 2008; Ito et al., 2005). The regenerative capacity of
hair follicles relies on a group of multipotent stem cells (bulge
cells) in the outer root sheath located just below the sebaceous
gland. When stimulated by physiological and pathological sig-
nals, bulge cells may transiently exit their slow-cycling niche
and give rise to matrix cells for hair regeneration (Cotsarelis
et al., 1990; Morris and Potten, 1994; Oshima et al., 2001) and
to epidermal cells for early wound repair (Ito et al., 2005, 2007;
Taylor et al., 2000).DeveRegulation of bulge cell activities involves many signaling
pathways, including Wnt/b-catenin, BMP/Smad, and Sonic
hedgehog (Shh) signaling. Wnt signaling activates bulge cells
to initiate anagen formation (Fuchs et al., 2004; Huelsken et al.,
2001), whereas BMP signals inhibit bulge cell activation by coun-
teracting Wnt signaling (Blanpain et al., 2004; Kobielak et al.,
2007; Kulessa et al., 2000; Plikus et al., 2008, 2011) and by pro-
moting Nfatc1 expression in bulge cells (Horsley et al., 2008).
Furthermore, Shh signaling has an established role in hair regen-
eration. Activation of Shh accelerates hair follicles into the
anagen phase (Paladini et al., 2005; Sato et al., 1999), whereas
blocking Shh signaling inhibits anagen induction and produces
hairless mice (Silva-Vargas et al., 2005; Wang et al., 2000).
Despite advances in understanding the molecular control of
bulge cell activities, little is known about the regulation of these
stem cells by chromatin-remodeling factors. Chromatin regula-
tors, by controlling the chromatin scaffold that packs the DNA
sequence, provide an important mechanism for gene expression
control. The ATP-dependent chromatin-remodeling complexes,
using the energy derived from ATP hydrolysis, can alter nucleo-
some positions and histone-DNA contacts, thus preparing the
genomic loci for transcriptional regulation. Although chromatin
remodelers are essential for many developmental processes
(Chang and Bruneau, 2012; Han et al., 2011; Ho and Crabtree,
2010; Lin et al., 2012), their roles in bulge cells, hair regeneration,
and epidermal replacement remain largely unknown.
Here we demonstrate that Brg1, an essential ATPase of the
BAF chromatin-remodeling complex, plays critical roles in bulge
stem cells during hair regeneration and epidermal repair. The
studies suggest a molecular circuit that integrates chromatin
remodeling (Brg1), transcriptional control (NF-kB, Gli), and inter-
cellular signaling (Shh) in different cell domains in the hair cycle to
orchestrate hair regeneration. These observations provide a
different perspective of bulge cell regulation through chromatin
remodelers.
RESULTS
Dynamic Expression of Brg1 in the Hair Follicle
To define the roles of Brg1 in hair regeneration, we examined the
expression of Brg1 at different hair-cycle phases, determined bylopmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Inc. 169
Figure 1. Brg1 Is Essential for Normal Hair Regeneration
(A–F) Immunostaining of Brg1 in telogen without hair germ (HG) (A), telogenwith small hair germ (B), telogen with larger hair germ (C), early anagen (D), mid anagen
(E), and late anagen (F) of the hair follicle. Higher magnification of bulge cells in late anagen (F, inset). Bu, bulge cells; DP, dermal papilla; Mx, matrix cells. Brg1,
pink; DAPI (DNA); blue; K15, green. Arrowheads indicate bulge cells that express Brg1.
(G) X-gal staining (blue) of the skin from Nfatc1Cre;R26R mice at P20.
(H and I) Brg1 immunostaining in the hair follicle of Brg1f/f (H) and Nfatc1Cre;Brg1f/f (I) mice at P22. Brg1, green; DAPI (DNA), blue. SG, sebaceous gland.
(J–M) Hair coat of Nfatc1Cre;Brg1f/f mice at P22 (J), P45 (K), P60 (L), and P150 (M).
(N–Q) Hematoxylin-eosin staining (HE) of hair follicles ofBrg1f/fmice at P22 (N) and P40 (P), as well as hair follicles ofNfatc1Cre;Brg1f/fmice at P22 (O) and P40 (Q).
(R–U) Ki67 immunostaining (brown) of hair follicle matrix cells of Brg1f/f at P22 (R) and P32 (T), as well as matrix cells of Nfatc1Cre;Brg1f/fmice at P22 (S) and P32
(U). Counterstain: hematoxylin.
(V) Quantitation of matrix cells. The matrix cell amount of hair follicles at P22 was set at 1. *, statistically significant. p values were calculated using the Student’s t
test. Error bars are data + 1 SE.
(W and X) Cross-sections of Brg1f/f (W) and Nfatc1Cre;Brg1f/f (X) skin at P120. HF, hair follicle.
See also Figure S1.
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Brg1, Shh, and Tissue Regenerationthe morphology and length of hair follicles, as well as the dis-
tance of the bulge to dermal papilla (Alonso and Fuchs, 2006).
By Brg1 immunostaining, we found that Brg1 was dynamically
expressed during the hair cycle. In bulge cells marked by K15,
Brg1 was undetectable in early telogen (Figure 1A), expressed
at a low level in late telogen (Figures 1B and 1C), but upregulated
at the telogen-to-anagen transition or early anagen (Figure 1D).
At late telogen to early anagen, Brg1 expression became more
apparent in the lower bulge (Figures 1C and 1D). However, by
mid to late anagen, Brg1 was turned off in the bulge (Figures
1E and 1F). The hair germ and matrix cells, unlike bulge cells,
had a higher level of Brg1 expression (Figures 1B–1F). Dermal
papilla, on the other hand, had dynamic Brg1 expression—
minimal/absent in telogen, low level from late telogen to early
anagen, and high level (comparable to matrix or hair germ cells)
by mid anagen (Figures 1A–1E). Overall, the dynamic expression
of Brg1 in the bulge coincides with bulge cell activation during
hair regeneration (Zhang et al., 2009).170 Developmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier IBrg1 Is Required for Physiological Hair Regeneration
To test whether bulge Brg1 was required for hair regeneration,
we deleted Brg1 in the bulge by crossing mice carrying floxed
Brg1 alleles (Brg1f) (Sumi-Ichinose et al., 1997) with mice
harboring Nfatc1Cre (Wu et al., 2012). Nfatc1Cre contains an
IRES-Cre cassette targeted to the 30 untranslated region of the
Nfatc1 locus and therefore directs Cre expression to the
Nfatc1-positive bulge (Horsley et al., 2008). Nfatc1Cre;R26R
reporter mice showed that Nfatc1Cre restricted gene recombi-
nation to bulge cells and their derivatives (Figure 1G). Neither
the postnatal epidermis nor embryonic day (E)17.5 skin had
Nfatc1Cre activity (Figure 1G; Figures S1A and S1B available
online). By immunostaining, we validated that Brg1 was deleted
in Nfatc1Cre;Brg1f/f mice at postnatal day (P)22 in bulge and
bulge-derived cells but not in the dermal papilla (Figures 1H
and 1I). There was no deletion of Brg1 in the epidermis or hair
follicles of E17.5 and P7 skin (Figures S1C–S1F). Brg1 deletion
in bulge cells at P22 after the first telogen is consistent with thenc.
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Brg1, Shh, and Tissue Regenerationexpression ofNfatc1 in quiescent but not proliferating bulge cells
(Horsley et al., 2008) and with the lack of bulge region until
3 weeks after birth (Cotsarelis, 2006; Nowak et al., 2008).
Nfatc1Cre is also active in the endocardium of midgestation
embryonic hearts (Wu et al., 2012) (data not shown). However,
we used an Nfatc1Cre subline that produced a limited deletion
of endocardial Brg1 (data not shown) to avoid potentially lethal
heart phenotypes. As such, most Nfatc1Cre;Brg1f/f mice
survived to adulthood and were grossly indistinguishable from
their littermates except that they gradually lost the hair coat
and became hairless (Figures 1J–1M). These observations sug-
gest a necessity of Brg1 for hair regeneration.
We then focused our analysis on the hair cycle of middorsal
skin from approximately P20 to P40, as described previously
(Alonso and Fuchs, 2006; Cotsarelis, 2006). By gross inspection
and histological analysis, we found that the initial phase of hair
growth or hair morphogenesis (Alonso and Fuchs, 2006) of
mutant (Nfatc1Cre;Brg1f/f) mice was normal. Their hair follicles
entered the first telogen at P19–P20 with normal morphology
(Figures S1G–S1O). However, when the control (Brg1f/f) follicles
exited telogen and began anagen at P22 (Figure 1N), mutant fol-
licles appeared foreshortened but with preserved hair density
and polarization (Figure 1O). Whereas control follicles continued
to elongate, mutant follicles displayed retarded growth and pro-
gressive distortion from P22 to P40 (Figures 1P and 1Q). Using
Ki67 to mark matrix cells (Kobielak et al., 2003), we found that
the matrix cells of control and mutant mice were comparable
at early anagen (P22) (Figures 1R and 1S). By P32, the matrix
cell number had increased 2-fold in control follicles but remained
unchanged in mutant follicles (Figures 1T–1V), consistent with a
failure of hair follicle growth. Despite these defects of mutant hair
follicles, the dermal papilla appeared normal by morphology and
by Pbx1 immunostaining—Pbx1 is a protein highly expressed in
mesenchymal tissues (Chang et al., 1995, 2008; Stankunas et al.,
2008b) and marked the dermal papilla (Figures S1P and S1Q).
Therefore, the growth retardation of mutant hair follicles began
at P22, with hair follicle morphology gradually distorted over
time (Figures 1W and 1X). The hair loss phenotype had 100%
penetration in more than 100 pairs of control and mutant mice
observed. The normal hair morphogenesis before the first telo-
gen in Nfatc1Cre;Brg1f/f mice is consistent with the absence of
Brg1 deletion and the absence of bulge region (and therefore
not functionally required) during the initial phase of hair growth
(Cotsarelis, 2006; Nowak et al., 2008). Collectively, these
findings suggest that Brg1 null follicles abort anagen soon after
they exit the first telogen.
By P40–P50, after the manifestation of hair follicle defects, the
epidermis appeared thickened in Nfatc1Cre;Brg1f/f mice (Fig-
ure 1Q) but without evidence of hyperkeratinization or abnormal
epidermal differentiation, as shown by normal keratin 5, keratin
10, and loricrin staining (Figures S1R–S1X). Also, there was no
evidence of skin inflammation—absence of redness or swelling,
negative staining for inflammatory markers (Cox2, Mac3,
MMP13), as well as the lack of increased mast cell infiltration
(toluidine blue staining) (data not shown). Because there was
no Brg1 deletion in the epidermis (Figure 1G; Figures S1A–
S1F), the thickening of epidermis is not caused by epidermal
Brg1 disruption. The data thus suggest that the hair follicle de-
fects ofmutantmice are not a consequence of skin inflammation.DeveBrg1 in Bulge Cells Is Essential for Hair Follicle and
Epidermal Replacement after Injury
To study Brg1’s function in hair and epidermal regeneration after
injury, we first determined whether the skin barrier was normal in
mutant mice. By toluidine blue staining (Indra et al., 2005), the
epidermis of Nfatc1Cre;Brg1f/f mice showed no permeability
defects either embryonically or postnatally (Figures S2A–S2D).
To test hair regrowth after injury, we depilated or shaved the
skin of control andmutantmice at P14 and examined hair growth
10 days later at P24. The control (Brg1f/f or Nfatc1Cre;Brg1f/+)
mice regrew the hair coat within 10 days, whereas the mutant
(Nfatc1Cre;Brg1f/f) mice failed to regrow the hair coat after
such injuries (Figures 2A and 2B). Histological analysis
confirmed the failure of hair growth in the mutant mice (Figures
2C and 2D).
To test epidermal regeneration, we performed full-thickness
skin incision inNfatc1Cre;Brg1f/f;R26Rmice and conducted line-
age-tracing experiments to track the fate of Cre-expressing
bulge cells. After skin incision, progeny of the control bulge cells
migrated toward and reached the incision site within 2 days (Fig-
ure S2E) and re-epithelialized the wounded skin within 9 days
(Figure 2E). In contrast, few cells derived from theBrg1 null bulge
cells ascended and reached the wounded epidermis, and they
failed to re-epithelialize the skin (Figure 2F; Figure S2F). Interest-
ingly, the skin injury induced remarkable Brg1 expression in
bulge and bulge-derived cells of control but notBrg1 null follicles
(Figures 2G–2I). Disruption of such injury-induced Brg1 activa-
tion caused a failure of the bulge-derived epidermal replacement
(Figure 2F) and a delay in early wound healing (measured by the
distance between the wound edges) (Figures 2J–2L). Collec-
tively, these data indicate a crucial role of Brg1 in bulge cells
for hair follicle and epidermal regeneration.
Brg1 Is Essential for Maintaining Bulge Stem Cell
Reservoir
Because of the progressive loss of hair coat in Nfatc1Cre;Brg1f/f
mice, we examined the amount of bulge cells by immunostaining
with bulge cell markers—Sox9, Nfatc1, and K15. We then semi-
quantitated the number of bulge cells in mutant mice at different
ages from P22 to P106 (Figures 3A–3J). The mutant mice had
normal amounts of bulge cells at P22 and P32, but their bulge
cells decreased by 60% at P40, >90% at P60, and 100% at
P106 (Figure 3K). These results suggest that Brg1 is essential
for the maintenance of the bulge stem cell pool.
To determine howBrg1maintained the bulge cell reservoir, we
first tested cell death or apoptosis by TUNEL staining and found
no apparent increased cell death in Brg1 null follicles with or
without depilation (Figures S3A–S3F and data not shown).
Because bulge cells are slow-cycling cells, we used hair depila-
tion to activate bulge cell proliferation and tested whether Brg1
was essential for bulge cell proliferation. Twenty hours after
depilation, we labeled the mice with bromodeoxyuridine (BrdU)
and harvested the skin 4 hr later. By BrdU/K15 coimmunostain-
ing, we observed that bulge cells in normal hair follicles incorpo-
rated BrdU, but not bulge cells in Brg1 null follicles (Figures 3L
and 3M). This BrdU incorporation study suggests that Brg1 is
necessary for the proliferation of bulge cells.
Next, we surveyed genes downstream of Brg1 that may be
involved in bulge cell proliferation. We knocked down Brg1 in alopmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Inc. 171
Figure 2. Brg1 Is Essential for Hair Follicle and Acute Epidermal Regeneration after Injury
(A and B) Hair growth 10 days after depilation (A) or shaving (B) performed at P14. N = 3 in each group.
(C and D) Histology of hair follicles 10 days after depilation of control (C) and mutant (D) follicles. HE, hematoxylin-eosin staining.
(E and F) X-gal staining of Nfatc1Cre;Brg1f/+;R26R (E) and Nfatc1Cre;Brg1f/f;R26R (F) skin 9 days after full-thickness skin incision.
(G–I) Immunostaining of Brg1 in the skin before wounding (G) and 6 days after wounding inBrg1f/f (H) andNfatc1Cre;Brg1f/f (I) mice. Brg1, green; DAPI (DNA), blue.
HF, hair follicle.
(J and K) Histology of the skin wound in Brg1f/f (J) and Nfatc1Cre;Brg1f/f (K) mice 6 days after full-thickness skin incision. The dashed lines indicate the distance
between the edges of the wound.
(L) Quantitation of the distance between wound edges relative to that of day 4 wound (4 days after incision). *, statistically significant.
p values were calculated using the Student’s t test. Error bars are data + 1 SE. See also Figure S2.
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Brg1, Shh, and Tissue Regenerationhuman bulge cell line (Roh et al., 2008) to survey cell-cycle genes
and then verified the findings in vivo. We validated the expres-
sion of bulge cell markers in this cell line. By immunostaining,
we showed that all human bulge cells, but none of the feeder
cells, expressed bulge cell markers K15 and SOX9 (Figures
S3G and S3H). Also, the human bulge cells expressed BRG1
but not the bulge cell suppressor NFATc1 (Horsley et al., 2008)
(Figure S3I and data not shown), consistent with their prolifera-
tive state. We knocked down BRG1 to test whether BRG1 was
essential for the proliferation of human bulge cells. To knock
down BRG1, we generated stable cells by infecting bulge cells
with lentivirus that allowed doxycycline-inducible expression of
shRNA against BRG1 (denoted as siBRG1). Reverse transcrip-
tion and quantitative PCR (RT-qPCR) and western blot analysis
showed that within 48 hr of doxycycline treatment, BRG1
mRNA was knocked down by 63% and BRG1 protein by 69%
in human bulge cells (Figures 3N and 3O; Figure S3J). Such
BRG1 knockdown severely impaired the proliferation of human
bulge cells, with 72% reduction of BrdU incorporation and
without cell apoptosis (Figures 3P–3S and 7F; data not shown)
(N = 6, each in triplicates), a finding consistent with the gradual
loss of Brg1 null bulge cells in vivo (Figure 3K). Therefore, both
the marker and proliferation studies suggest that the human
bulge cells, like those in the mouse, require Brg1 for their
proliferation.
Further RT-qPCR analysis of siBRG1 bulge cells, after
removing the NIH 3T3 feeder cells, revealed a 1.6-fold increase
of the cell-cycle inhibitor p27Kip1 (p < 0.001) without significant
changes in other cell-cycle genes that included cdk4, cdk6,
cyclin D1, cyclin D2, and p16INK4a (Figure 3T). To verify the172 Developmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Iexpression of p27Kip1 in vivo, we immunostained hair follicles
and found an increase of p27Kip1 in Brg1 null bulge cells and
matrix cells (Figures 3U–3X). This indicates that Brg1 suppresses
p27Kip1 in vivo. Because Brg1 was activated at late telogen to
early anagen (Figures 1A–1F), the suppression of p27Kip1 by
Brg1 at this window coincided with the timing of activation of
bulge cells to self-renew (Zhang et al., 2009). The transcriptional
changes of p27Kip1, indeed, are implicated in governing the slow
cycling of bulge cells (Blanpain et al., 2004). The suppression of
p27Kip1 by Brg1 therefore contributes, at least in part, to the
proliferation of bulge cells and the maintenance of the stem
cell reservoir.
Brg1 Is Necessary for Shh Expression in the Matrix
Deletion of Brg1 in bulge cells caused hair follicles to arrest at
early anagen of the first hair regeneration cycle (Figures 1N–
1Q). To identify genes responsible for such anagen defects, we
examined the following pathways crucial for anagen regulation:
Wnt/b-catenin, TGF-b, Jagged/Notch, and Shh (reviewed by
Blanpain and Fuchs, 2006). For Wnt signaling, we found
b-catenin expression had no significant changes in Nfatc1-
Cre;Brg1f/f follicles at P22 and P32 (Figures 4A–4D). We also
tracked Wnt activity using TOPGAL reporter mice (DasGupta
and Fuchs, 1999) and found no significant changes of Wnt
activity at P22 and P40 in the follicles of Nfatc1Cre;Brg1f/f;
TOPGAL mice (Figures S4A–S4D). By immunostaining, we
observed that phospho-Smad2/3 proteins were normal in the
mutant follicles at P30, suggesting no disturbance of TGF-b
signaling (Figures 4E and 4F). Also, RNA in situ hybridization
showed normal Jagged1 in the mutant follicles at P30 (Figuresnc.
Figure 3. Brg1 Is Essential for Maintaining
the Bulge Stem Cell Pool
(A and B) Immunostaining of Sox9 in the hair follicle
of Brg1f/f (A) and Nfatc1Cre;Brg1f/f (B) mice at
P106. Bu, bulge. Sox9, red; DAPI (DNA), blue.
(C–H) Immunostaining of Nfatc1 in the hair follicle
at P22 (C and D), P32 (E and F), and P60 (G and H)
in Brg1f/f (C, E, and G) and Nfatc1Cre;Brg1f/f (D, F,
and H) mice. DAPI, blue; Nfatc1, green.
(I and J) Immunostaining of K15 in the hair follicle of
Brg1f/f (I) and Nfatc1Cre;Brg1f/f (J) mice at P40.
DAPI, blue; K15, red.
(K) Quantitation of bulge cell amount. p values
were calculated using the Student’s t test. Error
bars are data + 1 SE.
(L and M) Coimmunostaining of K15 and BrdU of
control (Brg1f/f; L) and mutant (Nfatc1Cre;Brg1f/f;
M) hair follicles. Hair was depilated at P22. Twenty
hours after depilation the mice were labeled with
BrdU for 4 hr, and the skin was harvested at the
end of 4 hr BrdU labeling. BrdU, green; DAPI, blue;
K15, red.
(N and O) RT-qPCR and western blot analysis of
Brg1 in human bulge cells infected with lentivirus
expressing doxycycline-dependent control (siCtrl)
or anti-BRG1 (siBRG1) shRNA. p values were
calculated using the Student’s t test. Error bars are
data + 1 SE.
(P–S) Growth of human bulge cells 48 hr after
infection with lentivirus expressing doxycycline-
dependent control (siCtrl; P and Q) or anti-BRG1
shRNA (siBRG1; R and S).
(T) Quantitation of gene expression by RT-qPCR
in human bulge cells infected with lentivirus
expressing doxycycline-dependent control (siCtrl)
or anti-BRG1 (siBRG1) shRNA. p values were
calculated using the Student’s t test. Error bars are
data + 1 SE.
(U–X) Immunostaining of K15 (green) and p27Kip1
(red) in Brg1f/f (U and W) and Nfatc1Cre;Brg1f/f
(V and X) hair follicles. DAPI, blue.
See also Figure S3.
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Brg1, Shh, and Tissue Regeneration4G and 4H). Interestingly, although Shh was normal at P7 before
Brg1 was deleted (Figures 4I and 4J), there was no or minimal
Shh transcript in the matrix cells of mutant follicles at P22 and
P32 (Figures 4K–4N; Figures S4E–S4J). Consistent with the
absence of Shh, Gli1 proteins, whose nuclear occupancy
requires Shh stimulation (Hatayama and Aruga, 2012; Kogerman
et al., 1999), were largely translocated to the cytoplasm inmutant
follicles (Figures 4O and 4P). Quantification of Gli1 nuclear-to-
cytoplasmic ratio showed an 82.2% reduction of Gli nuclear
occupancy in mutant follicles (Figure 4Q). These findings indi-
cate that Brg1 is required for the expression of Shh, which
encodes a hedgehog ligand critical for anagen formation
(Silva-Vargas et al., 2005; Wang et al., 2000).
Brg1 Binds to and Activates the Shh Promoter
To determine how Brg1 activated Shh, we used chromatin
immunoprecipitation (ChIP) to examine Brg1’s binding to the
Shh promoter. With sequence alignment (http://www.dcode.
org), we identified eight evolutionarily conserved regions
(S1–S8) in the proximal 4.5 kb promoter of mouse Shh (Fig-
ure 5A). ChIP analyses of P22 Brg1f/f skin using anti-Brg1 anti-Devebody (Hang et al., 2010; Stankunas et al., 2008a) showed that
Brg1 was highly enriched within the Shh S1–S8 regions (Fig-
ure 5B) but not in the nonconserved Shh promoter regions (Fig-
ure 5C) or in gene promoters that are not active in the skin, such
as a-MHC, b-MHC, and Bmp10 (Hang et al., 2010) (Figures 5C
and 5D). Conversely, ChIP analyses of P22 Nfatc1Cre;Brg1f/f
skin showed no such Brg1 enrichment on the Shh promoter (Fig-
ure 5B). These ChIP results suggest that Brg1 binds to Shh
promoter in vivo.
To addresswhether Brg1 could coordinate with transcriptional
machinery to activate Shh promoter, we used the conventional
transient transactivation or reporter assay. We cloned the prox-
imal 4.5 kb of Shh promoter into an episomal luciferase reporter
pREP4, a promoter template that undergoes chromatinization in
mammalian cells and faithfully reflects the in vivo Brg1 activity on
target gene promoters in other tissues (Hang et al., 2010; Li et al.,
2013; Liu et al., 2001; Stankunas et al., 2008a). Because the
human bulge cells were resistant to transfection by various
methods (data not shown), we opted to use the highly trans-
fectable 293T cells, which like all cells have basal transcrip-
tional machinery, for transient transactivation assays. We thenlopmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Inc. 173
Figure 4. Brg1 Is Required for Shh
Expression
(A–D) b-catenin staining (red) of hair follicles of
Brg1f/f (A and C) and Nfatc1Cre;Brg1f/f (B and D) at
P22 and P32. Insets: magnified pictures of
b-catenin staining show nuclear localization.
(E and F) Immunostaining of pSmad2/3 (brown) in
hair follicles of Brg1f/f (E) and Nfatc1Cre;Brg1f/f (F)
mice at P30. Counterstain: hematoxylin (blue).
(G and H) RNA in situ hybridization of
Jagged1 (blue) in hair follicles of Brg1f/f (G) and
Nfatc1Cre;Brg1f/f (H) mice. Counterstain: nuclear
fast red. Arrows indicate the RNA expression (blue)
pattern for Jagged1.
(I–N) RNA in situ hybridization of Shh (blue) in
hair follicles of Brg1f/f (I, K, and M) and
Nfatc1Cre;Brg1f/f (J, L, and N)mice at P7, P22, and
P32. Counterstain: nuclear fast red. Arrows indi-
cate the RNA expression pattern for Shh.
(O and P) Immunostaining of Gli1 (green) in hair
follicles of Brg1f/f (O) and Nfatc1Cre;Brg1f/f (P)
mice. DAPI (DNA), blue. Insets: magnified pictures
of Gli1-positive cells. Arrows indicate Gli1-positive
cells.
(Q) Quantification of the ratio of nuclear-to-cyto-
plasmic Gli1 staining fluorescence intensity in the
hair follicles of Brg1f/f and Nfatc1Cre;Brg1f/f.
p values were calculated using the Student’s t test.
Error bars are data + 1 SE. See also Figure S4.
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Brg1, Shh, and Tissue Regenerationtransfected the Shh reporter and Brg1-expressing plasmids
(Hang et al., 2010) into 293T cells and measured the luciferase
activity driven by Shh promoter. We found that Brg1 activated
Shh promoter by 2.6-fold (Figures 5E and 5I). These transactiva-
tion studies, together with the in vivo binding of Brg1 to the Shh
promoter, suggest that Brg1 activates the Shh promoter.
Brg1 Recruits NF-kB to Shh Promoter to Activate Shh
Expression
We next examined potential transcription cofactors of Brg1 in
Shh activation. Because the NF-kB transcription factor is essen-
tial for Shh expression in pancreatic cancer cells (Nakashima174 Developmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Inc.et al., 2006) and for hair follicle develop-
ment in embryos (Schmidt-Ullrich et al.,
2006), we asked whether Brg1 interacted
with NF-kB to regulate Shh in postnatal
follicles. We first examined the expres-
sion of NF-kB by immunostaining, which
showed that NF-kB proteins were widely
present in both the control and mutant
hair follicles at P22 (Figure 5F). Coimmu-
noprecipitation revealed that NF-kB
formed a physical complex with Brg1 in
the P22 skin (Figure 5G). To test whether
NF-kB also bound to the Shh promoter,
we performed ChIP analysis of the P22
skin and found that NF-kB, like Brg1,
was highly enriched on the conserved re-
gions (S1, S4–S8) of Shh promoter (Fig-
ure 5H). Interestingly, these sites with
Brg1 binding also contain NF-kB bindingsites, as predicted by TRANSFAC (http://www.dcode.org) (Fig-
ure S5), with the exception of S7, whose signals likely came
from cryptic NF-kB sites or from its close proximity to S8 due
to the resolution of the ChIP assay. Conversely, in the P22
mutant skin, NF-kBwas unable to bind to thoseShh regions (Fig-
ure 5H), suggesting that NF-kB requires Brg1 to assist its binding
to the Shh promoter.
To further define Brg1-NF-kB interactions on the Shh pro-
moter, we used IkB to knock down NF-kB activity (Zhou et al.,
2003) and tested the Brg1-dependent Shh activation in transient
transactivation assays. The IkB-expressing, Brg1-expressing,
and Shh promoter plasmids were cotransfected into 293T cells.
Figure 5. Brg1 Recruits NF-kB to Activate
Shh Expression
(A) Sequence alignment of the Shh locus from
mouse, monkey, human, and rat. Peak heights
indicate degree of sequence homology. Black
boxes (S1–S8) are regions of high sequence
homology and were further analyzed by ChIP.
Red, promoter elements; salmon, introns; yellow,
untranslated regions; blue, coding exons; green,
transposons and simple repeats.
(B) PCR analyses of Brg1-immunoprecipitated
chromatin from P22 control (Ctrl; Brg1f/f) and
mutant (Mut; Nfatc1Cre;Brg1f/f) dorsal skin. Rb-
IgG, rabbit IgG.
(C) Sequence alignment of the Shh locus from
mouse, monkey, human, and rat. Peak heights
indicate degree of sequence homology. Black
boxes (SC1–SC4) are regions of no sequence
homology and were further analyzed by ChIP.
(D) PCR analyses of Brg1-immunoprecipitated
chromatin from Brg1f/f skin using primers targeting
the nonconserved regions of Shh (SC1–SC4) and
a-MHC, b-MHC, and Bmp10 (P1–P4). Bmp10,
bone morphogenic protein 10; MHC, myosin
heavy chain; SC, Shh control genes.
(E) Luciferase reporter assay of the Shh promoter.
p values were calculated using the Student’s t test.
Error bars are data + 1 SE.
(F) Immunostaining of NF-kB (brown) in the hair
follicle of Brg1f/f (left) and Nfatc1Cre;Brg1f/f (right)
mice. Counterstain: hematoxylin.
(G) Coimmunoprecipitation of Brg1 and NF-kB in
P22 skin. a-Brg1, G-7mousemonoclonal antibody
against Brg1; a-NF-kB, rabbit polyclonal antibody
against NF-kB; Ms-IgG, mouse IgG.
(H) PCR analyses of NF-kB-immunoprecipitated
chromatin from P22 control (Ctrl; Brg1f/f) and
mutant (Mut; Nfatc1Cre;Brg1f/f) dorsal skin.
(I and J) Luciferase reporter assays of the Shh
promoter with transfected Brg1 and IkB.
p values were calculated using the Student’s t test.
Error bars are data + 1 SE. See also Figure S5.
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dependent Shh activation by 42% (from 2.6- to 1.5-fold,
p < 0.0001) (Figure 5I), suggesting that Brg1 requires NF-kB to
activate Shh promoter. On the other hand, the transfection of
Brg1 enhanced NF-kB-dependent Shh promoter activation by
2.2-fold (from 25% to 56% repression, p < 0.001) (Figure 5J),
indicating that NF-kB requires Brg1 to activate Shh pro-
moter. Thus, Brg1 and NF-kB cooperatively activate Shh pro-
moter. Because NF-kB depended on Brg1 to bind to the Shh
promoter (Figure 5G), the collective ChIP and transactivation
analyses suggest that Brg1 recruits NF-kB to the Shh promoter
to activate its expression.
Shh Is Sufficient and Necessary for Brg1 Expression
in the Bulge and Matrix
We observed that treating skin with an Shh/smoothened agonist
(SAG) (Chen et al., 2002) resulted in acceleration of hair growth
(Paladini et al., 2005). Also, we found that SAG treatment upregu-
lated Brg1 expression in bulge cells (Figures 6A and 6B). These
findings led us to hypothesize that Shh was essential for Brg1
activation to regulate hair growth. To test this hypothesis, weDeveused the smoothened antagonist cyclopamine (Chen et al.,
2002) to block Shh signaling in the skin and found that cyclop-
amine inactivated Brg1 expression in bulge, hair germ, and
matrix cells (Figure 6C). These results revealed an in vivo
sufficiency and necessity of Shh signaling for Brg1 activation in
those hair follicle cells.
Shh Requires Brg1 to Stimulate Hair Regeneration after
Injury
Because Shh activated Brg1 expression in the hair follicle, we
asked whether Brg1 could be a downstream effector of Shh
signaling for hair regeneration. To test the hypothesis, we chose
to examine hair regrowth between P15 and P22, before the Brg1
mutant mice displayed hair coat changes (Figure 1J). We shaved
the dorsal skin of control Brg1f/f and mutant Nfatc1Cre;Brg1f/f
mice at P15 and treated these mice with SAG. Seven days later
at P22, we examined the mice for the regrowth of their hair coat.
Control mice without SAG treatment showed partial hair growth,
whereas the SAG-treated control mice had fully regrown the hair
coat (Figures 6D and 6E). Conversely, SAG was unable to trigger
hair growth in Brg1 null follicles (Figures 6F and 6G). Theselopmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Inc. 175
Figure 6. Shh Signaling Activates Brg1 Expression in Bulge and Matrix Cells
(A–C) Immunostaining of K15 (green) and Brg1 (red) in hair follicles 35 hr after treatment with DMSO (A), SAG (B), or cyclopamine (C). DAPI (DNA), blue. Bu, bulge;
DP, dermal papilla; HG, hair germ.
(D–G) Dorsal skin of Brg1f/f (Ctrl; D and E) and Nfatc1Cre;Brg1f/f (Mut; F and G) mice at P22, 7 days after shaving (at P15) with (E and G) or without (D and F) SAG
treatment.
(H–J) RNA in situ hybridization of Shh in the hair follicle in telogen (H), anagen initiation (I), and early anagen (J). Arrows in (I) indicate hair germ cells.
(K–M) Immunostaining of Patched1 (Ptch1; red) in bulge (K and L) and matrix (M) cells. Mx, matrix cells; SG, sebaceous gland.
(N and O) Quantitation of BRG1 in human bulge cells treated with DMSO vehicle or SAG (N) or cyclopamine (O).
(P) Schematics of the positions of B1–B4 primer sets on theBRG1 promoter and PCR analyses of Gli1- or Gli2-immunoprecipitated chromatin from untreated and
SAG- and cyclopamine-treated bulge cells. Rb-IgG, rabbit IgG.
(Q) Quantitation of BRG1 mRNA in bulge cells infected with retrovirus expressing GFP (green fluorescence protein) or Gli1.
(R) Luciferase reporter assay of the BRG1 promoter in human bulge cells infected with GFP or Gli1 or Gli2 retrovirus.
For (N), (O), (Q), and (R), p values were calculated using the Student’s t test. Error bars are data + 1 SE.
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regrowth after injury.
We next looked for potential sources of Shh that might activate
Brg1. ByRNA in situ hybridization, we found no detectableShh in
telogen hair follicles. However, low ShhmRNA level was present
in the bulge and hair germ at telogen-anagen transition or early
anagen (Figures 6H–6J), whereas amuch higher ShhmRNA level
was observed in the matrix cells (Figures 4I, 4K, and 4M). This
pattern of Shh expression is consistent with previous reports
(Blanpain and Fuchs, 2006; Oro and Higgins, 2003). Further-
more, by immunostaining, we observed that Ptch1—the Shh
receptor—was abundant in bulge and matrix cells (Figures 6K–
6M), indicating that Shh signals can reach both the matrix and
bulge. These observations, although not excluding other sources
of Shh (Brownell et al., 2011), suggest that the hair germ and
matrix cells can secrete Shh—a short- and long-range signaling176 Developmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Imolecule that can signal cells both locally and at a distance
(Johnson and Tabin, 1995; Zeng et al., 2001)—to activate Brg1
in adjacent matrix and bulge cells.
Shh Signals through Gli to Activate Brg1
Previous studies show that Gli1, a downstream transcriptional
effector of Shh, is expressed in the bulge and marks bulge cells
capable of self-renewal (Brownell et al., 2011). This observation,
together with our finding that Shh was essential for Brg1 expres-
sion in the bulge, suggests that Shh signals through Gli to acti-
vate bulge Brg1. To validate the response of human bulge
cells to Shh, we treated the human cells with SAG and cyclop-
amine and measured their BRG1 expression. RT-qPCR showed
SAG enhanced BRG1 mRNA by 1.95-fold (p < 0.02) (Figure 6N),
whereas cyclopamine reduced BRG1mRNA by 44% (p < 0.012)
(Figure 6O). Therefore, Shh is both necessary and sufficient fornc.
Figure 7. Partial Rescue of Cell Defects by
Shh in BRG1-Deficient Human Bulge Cells
(A–D) Growth of human bulge cells 48 hr after
doxycycline (Dox) treatment and siCtrl (A and C) or
siBRG1 (B and D) infection in the absence (A and
B) or presence (C and D) of human recombinant
SHH (rSHH).
(E–H) BrdU incorporation of human bulge cells
48 hr after Dox treatment and siCtrl (E and G) or
siBRG1 (F and H) infection in the absence (E and F)
or presence (G and H) of rSHH. Arrows indicate
BrdU-positive cells.
(I) Quantification of BrdU incorporation in siCtrl ±
rSHH and siBRG1 ± rSHH groups.
(J and K) Quantitation of BRG1 and p27Kip1
expression in human bulge cells 48 hr after Dox
treatment and siCtrl or siBrg1 lentiviral infection in
the absence (J) or presence (K) of rSHH. For (I)–(K),
p values were calculated using the Student’s t test.
Error bars are data + 1 SE.
(L) Working model of Brg1 function in the hair fol-
licle. Brg1 suppresses p27Kip1 to regulate self-
renewal of bulge stem cells. Brg1 recruits NF-kB to
activate Shh in matrix cells, which then feed back
to activate Brg1 in bulge cells through Gli.
See also Figure S6.
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Shh in mice (Figures 6A–6C). These results suggest a conserved
transcriptional mechanism by which Shh activates bulge Brg1.
We then askedwhether Gli proteins, the downstream effectors
of Shh signaling, could bind to BRG1 promoter and then activate
BRG1 in bulge cells. We designed a primer set (B1) that targeted
the proximal BRG1 promoter and three primer sets (B2–B4) that
targeted putative Gli binding sites (Sasaki et al., 1997) on the
BRG1 promoter (Figure 6P). ChIP analysis of the human bulge
cells showed that both Gli1 and Gli2 were highly enriched in
the B2 and B4 sites of BRG1 promoter; SAG enhanced and
cyclopamine reduced the ChIP signals of Gli1 and Gli2 on these
sites (Figure 6P). The results indicate that Gli proteins are trig-
gered by Shh signals to bind to the BRG1 promoter. To test
the activation of BRG1 by Gli, we infected the human bulge cells
with Gli1-expressing retrovirus. Expression of Gli1 resulted in a
6.43-fold increase (p < 0.0079) of BRG1 mRNA (Figure 6Q).
Further reporter analysis in 293T cells showed that Gli1 andDevelopmental Cell 25, 169–1Gli2 activated Brg1 promoter activity by
2.11- and 1.73-fold, respectively (p <
0.0001) (Figure 6R). These ChIP, BRG1
activation, and reporter studies thus sug-
gest that Gli binds and activates BRG1
promoter in human bulge cells. Together
with the in vivo data, these findings indi-
cate that Shh signals through Gli to acti-
vate Brg1 expression.
Partial Rescue of Cellular Defects
by Shh in BRG1-Deficient Human
Bulge Cells
To further test the reciprocal interaction
between Brg1 and Shh at the cell level,we performed rescue experiments to see whether exogenous
Shh or Shh driven by a heterologous promoter could at
least partially rescue the cell proliferation defect or p27Kip1 mis-
regulation in human bulge cells with BRG1 knocked down. We
used recombinant human Shh protein (rSHH) and doxycycline
to treat siBRG1 bulge cells and examined cell proliferation
and p27Kip1 expression. Forty-eight hours after treatment,
siBRG1 bulge cells showed defects in cell proliferation (72%
reduction of BrdU incorporation) without cell apoptosis (Figures
7B and 7F; data not shown). rSHH treatment partially rescued
cell proliferation, BrdU incorporation, and p27Kip1 abnormalities
(Figures 7D and 7H–7K). Similarly, Shh driven by a heterologous
CMV promoter in a lentiviral construct partially rescued
the cell proliferation defect and p27Kip1 misexpression of
siBRG1 bulge cells (Figures S6A–S6F). The partial rescue
by Shh of certain bulge cell defects when BRG1 is partly defi-
cient but not when Brg1 is completely disrupted (Figures
6D–6G) is consistent with a positive feedback loop in which81, April 29, 2013 ª2013 Elsevier Inc. 177
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functions.
DISCUSSION
Reciprocal Brg1-Shh activation provides a tissue feedback loop
between bulge and matrix cells to control hair regeneration (Fig-
ure 7L). Disruption of this feedback loop by deletingBrg1 (current
studies) or inhibiting Shh signaling (Silva-Vargas et al., 2005;
Wang et al., 2000) produces identical phenotypes—anagen
failure, hair loss, and impaired tissue repair. Brg1 forms a molec-
ular circuitry with Shh, each enlisting a transcription factor,
NF-kB or Gli, to activate each other in different cell domains of
the hair cycle. Shh activates bulge Brg1 to promote early hair
growth, whereas Brg1 activates matrix Shh to sustain hair
growth until catagen breaks in.
A Geometric Model for the Dynamics and Tissue
Domains of Brg1 Expression
Our studies reveal a mechanistic mode of how Brg1 interacts
with Shh signaling: Brg1 recruits NF-kB to activate Shh expres-
sion, and Shh signals through Gli to activate Brg1 expression. It
will be interesting to further investigate whether bulge/matrix
Brg1 could directly control the expression of Shh target genes,
as reported in the neural tissues (Zhan et al., 2011).
In the hair cycle, Brg1 dynamics may be determined by the
signaling range of Shh. The developing hair germ and matrix
cells express Shh and can thus secrete Shh to activate Brg1
in an autocrine or paracrine fashion. The presence of Shh
receptor (Ptch1) in bulge, hair germ, and matrix cells indicates
that Shh signaling spans the entire matrix and bulge, where
Brg1 requires Shh to be activated. At late telogen to early
anagen, the hair germ/matrix cells (Shh sources) are in close
proximity to the bulge, which is therefore within the signaling
range of Shh that causes Brg1 activation. As anagen pro-
gresses and the hair follicle elongates, the sources of Shh
(hair germ and matrix cells) move farther away from the bulge,
and bulge cells are now beyond the signaling range of Shh,
thus turning off Brg1. Conversely, because of the availability
of local matrix Shh during anagen, matrix Brg1 expression is
maintained throughout anagen. Matrix Brg1 recruits NF-kB
to activate Shh, sustaining a positive feedback loop in the
matrix for continued hair growth. How this matrix Brg1-Shh
loop breaks when anagen ends and catagen ensues requires
further study.
This geometric model suggests a mechanism of how the
matrix-bulge physical distance may play a tissue feedback role
in the control of hair regeneration. In addition, Shh from other
cellular sources may activate Brg1 in the bulge. For example,
nerve-derived Shh can maintain a niche of bulge cells capable
of becoming epidermal stem cells (Brownell et al., 2011). These
findings suggest that distinct sources of Shh may activate Brg1
in discrete subpopulations of bulge cells to carry out different
regenerative functions—hair regeneration or epidermal replace-
ment. More studies will be needed to elucidate the detailed
mechanisms by which bulge cells segregate into distinct stem
cell populations.
Alternative to, but not excluding, the geometric model of bulge
Brg1 activation is the possible existence of additional factors178 Developmental Cell 25, 169–181, April 29, 2013 ª2013 Elsevier Ithat dynamically regulate Brg1 in the bulge. For example, the
oscillation of Wnt/b-catenin and Bmp signaling during the hair
cycle may converge to orchestrate factors that control the
dynamics of Brg1, leading to specific temporospatial pattern of
Brg1 expression. Future identification of such factors and how
they integrate with Wnt, Bmp, and Shh signaling will be essential
to understand the cycling mechanisms of Brg1 and hair follicle
regeneration.
Maintenance of the Bulge Stem Cell Pool by Brg1
Brg1 null bulge cells ectopically express the cell-cycle inhibitor
p27Kip1, which contributes to the defects of cell proliferation,
an essential part for bulge cell self-renewal and replenishment
of the stem cell pool. The suppression of p27Kip1 occurs at the
onset of anagen when Brg1 is activated (Figures 1A–1F). This
window of p27Kip1 suppression coincides with the timing of
bulge cell self-renewal and production of daughter cells (Zhang
et al., 2009), indicating a critical role of the Brg1-p27Kip1 pathway
in the regulation of bulge cell self-renewal. Indeed, transcrip-
tional changes of p27Kip1 are implicated in the control of bulge
cell cycling (Blanpain et al., 2004). Cyclic Brg1 activation may
periodically unleash bulge cells from the chronic constraints
by p27Kip1 and/or other suppressors, thereby triggering bulge
cells to enter a proliferative, self-renewing state. Because Brg1
is a chromatin remodeler, these results suggest that chromatin
restructuring to regulate gene expression is important for bulge
cells to switch between quiescent and proliferative states.
Future investigations of Brg1 null bulge cells will be important
to identify other downstream genes involved in the self-renewal
control process.
Pathophysiological Activation of Brg1 for Tissue Repair
and Homeostasis
Brg1 plays critical roles in hair follicle and epidermal regeneration
after injury. Depilation activates Brg1 to regrow hair follicles, and
skin incision activates Brg1 to produce epidermal cells to accel-
erate wound healing. These findings are consistent with the
ability of depilation and wounding to induce hair follicles into
anagen phase. Brg1 therefore serves as a stress-activated
mechanism to reprogram bulge cells for tissue repair. In the
absence of bulge-derived epidermis, we observed that interfol-
licular epidermal cells are activated to express Brg1 and
re-epithelialize the wound (Figures 2F and 2I). This finding sug-
gests an additional role of Brg1 in epidermal cells for wound
repair—when bulge cells are not functioning. On the other
hand, the epidermis of Nfatc1Cre;Brg1f/f mice becomes thick-
ened over time, despite the absence of epidermal Brg1 deletion
in these mice. Such epidermal thickening may suggest that Brg1
can function non-cell-autonomously in the bulge or bulge-
derived cells to regulate epidermal cell biology. Developmen-
tally, Brg1 is required in the epidermis to regulate the perme-
ability function of the skin barrier in mouse embryos (Indra
et al., 2005). However, it remains unclear whether Brg1 functions
in the postnatal epidermis for skin homeostasis. Further investi-
gations will be essential to determine how Brg1 orchestrates the
epidermal-bulge interaction.
Our studies show that Brg1 is a key chromatin remodeler
whose tissue expression in the hair follicle is highly sensitive to
physiological and pathological signals. The regulation of Brg1nc.
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framework for us to further explore how hair follicles respond




Brg1f/f (Sumi-Ichinose et al., 1997),Nfatc1Cre (Wu et al., 2012),R26R (Soriano,
1999), and TOPGAL (DasGupta and Fuchs, 1999) mice have been described.
The use of mice for these studies is in compliance with the regulations of
Stanford University and the National Institutes of Health.
Skin Harvest, Histology, Immunostaining, RNA In Situ Hybridization,
and X-Gal Staining
Skin was harvested from the middorsal region. Different hair-cycle phases
were determined by the morphology, length of hair follicles, and distance of
the bulge to dermal papilla (Alonso and Fuchs, 2006). Histology, immunostain-
ing, RNA in situ hybridization, and X-gal staining were performed as described
(Chang et al., 2004). Information regarding primary antibodies used for immu-
nostaining is detailed in Supplemental Experimental Procedures. The number
of matrix cells was quantitated from 10–20 comparable hair follicle sections of
four to six mice per group. The number of bulge cells was quantitated from
6–10 comparable hair follicle sections from four to six mice per group stained
with three different bulge cell markers (Nfatc1, K15, and Sox9). For depilation
and BrdU labeling, the midback hair was plucked by hemostatic forceps. After
20 hr, the mice were treated with 50mg/kg BrdU intraperitoneally, and the skin
was harvested after 4 hr BrdU labeling. The probes used for RNA in situ
hybridization are described in the text.
Full-Thickness Skin Incision
Full-thickness, middorsal, shaved skin tissues (13 0.5 cm) were excised along
the dorsal midline of the mice. The skin wound was closed by 6-0 silk sutures
and harvested 4, 6, 8, and 12 days after closure for analysis. The wound size
was defined by the length between the edges of the wound.
Chromatin Immunoprecipitation
ChIP was modified from a previous description (Hang et al., 2010). Six to eight
pieces of P22 middorsal skin were used for one ChIP experiment. For bulge
cell ChIP, 3–6 3 106 cells were used for one ChIP reaction. Chromatin was
sonicated to an average size of 200–500 bp and immunoprecipitated using
anti-Brg1 J1 antibody, anti-NF-kB antibody, anti-Gli1 (ab49314; Abcam),
anti-Gli2 (ab26056; Abcam), or rabbit IgG. DNA from precipitated chromatin
was PCR amplified for 32–34 cycles. PCR primers are described in Supple-
mental Experimental Procedures.
Luciferase Reporter Assays
Reporter assays were previously described (Hang et al., 2010). A dominant
mutant IkB expression plasmid that blocks the activity of NF-kB and its control
plasmid were gifts from Muxiang Zhou (Emory University School of Medicine)
(Zhou et al., 2003). Plasmids (pGIPZ-siBrg1 and pGIPZ-siCtrl) expressing
shRNAs against human BRG1 and scramble RNA control were described
(Stankunas et al., 2008a). The mouse Shh promoter (4358 to +85) and
Brg1 promoter (4953 to +252) were cloned into pREP4-Luc reporter plasmid
(Liu et al., 2001). Gli1, Gli2, and GFP expression plasmids were gifts from
James Chen (Stanford University). Constructs were transfected into 293T cells
with Lipofectamine (Invitrogen) with Renilla control pREP7-RL. Firefly lucif-
erase was normalized to Renilla luciferase activity using the Dual-Luciferase
Reporter System (Promega).
Drug Treatment
Themiddorsal skin was shaved and 100 ml of DMSO vehicle or SAG (0.25 mg/ml)
(sc-202814; Santa Cruz Biotechnology) was topically applied twice a day.
Cyclopamine (S1146; Selleck Chemicals) was injected intraperitoneally at
25 mg/g body weight along with topical application of 100 ml (0.25 mg/ml)
once daily.DeveLentiviral Infection and Selection
The pGIPZ lentiviral construct that encodes shRNAs against humanBRG1was
purchased from Open Biosystems. The MluI and XhoI fragment from pGIPZ
containing the hairpin was cloned into a doxycycline-inducible lentiviral vector,
TRIPZ (Open Biosystems). The lentivirus was produced in 293T cells and used
to infect bulge cells. To generate bulge cell lines with stable lentiviral infection,
we made a puromycin-resistant NIH 3T3 feeder cell line. Infected bulge cells
were amplified for 7 days, replated on puromycin-resistant NIH 3T3 cells,
and then selected with 2 mg/ml puromycin for 10 days. Doxycycline was
used to induce shRNA expression in the stable bulge cell line.
Human Bulge Cell Culture
Human bugle cells were cocultured with NIH 3T3 feeder cells as described
(Roh et al., 2008). For SAG treatment, bulge cells were cultured in media
with 1% fetal bovine serum (FBS) overnight for serum deprivation and then
treated with 10 mMSAG. For cyclopamine treatment, bulge cells were cultured
in media with 5% FBS and treated with 10 mM cyclopamine. Six hours after
SAG or cyclopamine treatment, the feeder cells were removed by Versene
(GIBCO). Bulge cells were then harvested and RNAs were extracted for RT-
qPCR analysis. For Gli experiments, pBMN-Gli1 and pBMN-GFP retroviral
vectors (Hyman et al., 2009) were provided by James Chen. The retrovirus
stock was prepared by transfecting Phoenix-Ampho cells using a calcium
phosphate precipitation. Bulge cells were infected with retrovirus and
harvested for BRG1 qRT-PCR analysis 48 hr postinfection.
Coimmunoprecipitation and Western Blotting
Nuclear extracts were prepared from the middorsal skin of P22 mice.
Precleared nuclear extracts were immunoprecipitated with no antibody
(input), mouse monoclonal anti-Brg1 (G-7; Santa Cruz Biotechnology), normal
mouse IgG (Santa Cruz Biotechnology), rabbit polyclonal anti-NF-kB p65
(Abcam), or normal rabbit IgG (DAKO). Immunoprecipitates were then western
blotted with anti-Brg1 (G-7; Santa Cruz Biotechnology) or anti-NF-kB p65
(Abcam).
Rescue Experiments with Recombinant Human SHH Proteins and
Lentivirus-Expressing SHH
The siCtrl and siBrg1 bulge cells were treated with/without doxycycline and
with/without 1 mg/ml active form of recombinant human SHH protein (R&D
Systems) for 48 hr before analysis. The full-length human SHH cDNA was
cloned into the lentiviral vector pCDH-CMV-MCS-EF1 (System Biosciences).
The lentivirus, produced in 293T cells, was used to infect bulge cells for
48 hr before cells were harvested.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
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